Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,009,039
Closed -$76.3M 1085
2026
Q1
$76.3M Buy
1,009,039
+11,149
+1% +$838K 0.29% 72
2025
Q4
$74.3M Buy
997,890
+77,499
+8% +$5.66M 0.29% 72
2025
Q3
$62.1M Sell
920,391
-157,842
-15% -$10.5M 0.29% 72
2025
Q2
$70.3M Buy
1,078,233
+930,748
+631% +$55.8M 0.37% 50
2025
Q1
$9.11M Buy
147,485
+3,413
+2% +$226K 0.06% 375
2024
Q4
$10.4M Buy
144,072
+18,072
+14% +$1.41M 0.07% 335
2024
Q3
$10.3M Buy
+126,000
New +$10.1M 0.09% 291
2021
Q4
Sell
-211,890
Closed -$15.6M 739
2021
Q3
$15.6M Buy
211,890
+132,441
+167% +$9.93M 0.26% 109
2021
Q2
$5.3M Sell
79,449
-103,509
-57% -$6.92M 0.1% 213
2021
Q1
$13.6M Sell
182,958
-164,766
-47% -$12.5M 0.3% 89
2020
Q4
$25.3M Buy
347,724
+38,804
+13% +$2.74M 0.67% 48
2020
Q3
$20.5M Sell
308,920
-139,138
-31% -$8.81M 0.67% 43
2020
Q2
$25.5M Buy
448,058
+278,252
+164% +$13.7M 1.01% 34
2020
Q1
$5.96M Sell
169,806
-131,098
-44% -$6.24M 0.43% 74
2019
Q4
$15.7M Buy
+300,904
New +$15M 0.64% 53

Other funds holding HOLX

Woodline Partners's HOLX Position: Q2 2026 in Review

Woodline Partners sold out of Hologic (HOLX) in Q2 2026, closing a stake of 1,009,039 shares — an estimated $76.3M sold.

Woodline Partners first reported a position in HOLX in Q4 2019 and held it in 15 quarters. The position peaked at $76.3M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Woodline Partners reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Woodline Partners sold 1,009,039 Hologic shares in Q2 2026, an estimated $76.3M.
  • Woodline Partners first reported a position in Hologic in Q4 2019 and held it in 15 quarters.
  • Woodline Partners's Hologic position peaked at $76.3M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.